$MRK (Merck & Co.) — 8-K: Merck adds Paul J. Diaz to board effective Nov. 1, 2026, expanding to 14 members

Paul J. Diaz, managing partner at Cressey Company, will join Merck's Board of Directors effective Nov. 1, 2026, and will stand for shareholder election in May 2027. The addition brings the Merck board to 14 members. Diaz previously served as president and chief executive officer of Myriad Genetics and Kindred Healthcare, and serves on the Board of Centene Corporation.

Paul J. Diaz, managing partner at Cressey Company, will join Merck's Board of Directors effective Nov. 1, 2026, and will stand for shareholder election in May 2027. The addition brings the Merck board